Medical News Today: What is atrial fibrillation?

Atrial fibrillation is a heart disease that leads to twitching and malfunction in the walls of the heart and irregular heart rhythm. This can cause a range of complications and can be fatal without treatment. Read on to learn about the symptoms and possible complications, as well as how to treat the condition.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Heart Disease Source Type: news

Related Links:

ConclusionEarly repolarization was associated with lone atrial fibrillation. Early repolarization may indicate increased susceptibility to atrial fibrillation.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Tags: ORIGINAL ‐ CLINICAL Source Type: research
ConclusionThis study reports unexpectedly high atrial fibrosis in non ‐AF patients without apparent heart disease, highlighting the concept that structural fibrotic alterations may precede AF onset in a significant proportion of individuals. Body‐mass index as a predictor of atrial fibrosis suggests that lifestyle and drug intervention, i.e. weight reduction, coul d positively influence fibrosis development. The derived risk score for AF prevalence provides the basis for prospective studies on AF incidence.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Tags: ORIGINAL ‐ CLINICAL Source Type: research
Electrophysiologists (EPs) who are managing atrial fibrillation (AF) patients who also suffer from sleep apnea have found that catheter ablation is most effective when used in conjunction with a CPAP regimen, yet there is a huge disconnect between the EPs and the sleep experts. That disconnect is what inspired Itamar Medical to develop SleePath, an integrated digital health sleep apnea care pathway monitoring system that allows cardiologists to monitor patients with AF sleep apnea status and compliance with CPAP devices on demand. The Caesarea, Isreal-based company unveiled SleePath last May at Heart Rhythm 201...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news
ConclusionAge ‐specific serum NT‐proBNP levels inform prognosis, and hence therapeutic decisions, regarding HF risk in individuals at increased CVD risk.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Tags: Research Article Source Type: research
Yajun Cheng, Junfeng Liu, Shuting Zhang, Jie Li, Chenchen Wei, Deren Wang, Jing Lin, Yanan Wang, Bo Wu, Shihong Zhang, Ming Liu
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Smart belt for weight loss, spider-like walking car, terrifying Robo-Sharks, IoT cat toilet, the real version of the monolith from Space Odyssey: the world’s most famous tech circus brings the superlatives of innovation to Las Vegas every year. Here, we sorted out the most exciting, the less useful or the outright dumbest health technology from CES 2019. The year of the solar cow What do power banks and cows have in common? The 2019 CES Innovation Award, actually. It’s a brilliant project of a South Korean solar energy company, Yolk, having partnered with a Kenyan educational institution, to keep children at s...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Future of Medicine ces CES 2019 digital digital health digital health tech gadgets health technology health trends Innovation smartwatch summit wearables Source Type: blogs
ConclusionDroxidopa is approved by the US Food and Drug Administration to treat symptomatic nOH and is not contraindicated in patients with cardiovascular conditions. In this case, treatment with droxidopa improved the patient ’s orthostatic tolerance and, importantly, did not change the patient’s rate-controlled AF or his symptoms of class IV heart failure. Because symptoms associated with nOH can be detrimental to patient safety and mobility, it is critical to screen for and treat patients with nOH, even when there are cardiovascular comorbidities.FundingEditorial support and article processing charges were f...
Source: Cardiology and Therapy - Category: Cardiology Source Type: research
Nonsteroidal anti-inflammatory drugs, commonly referred to as NSAIDs, are one of the most common medications used to treat pain and inflammation. Ibuprofen, naproxen, indomethacin, and other NSAIDs are effective across a variety of common conditions, from acute musculoskeletal pain to chronic arthritis. They work by blocking specific proteins, called COX enzymes. This results in the reduction of prostaglandins, which play a key role in pain and inflammation. There are two types of NSAIDs: nonselective NSAIDs and COX-2 selective NSAIDs (these are sometimes referred to as “coxibs”). There has been a growing body ...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Drugs and Supplements Health Heart Health Source Type: blogs
CONCLUSION: The evidence base for anticoagulation over a time frame of several years is inadequate at present, and direct comparative data for the different types of NOAC are not yet available. PMID: 30602410 [PubMed - in process]
Source: Deutsches Arzteblatt International - Category: General Medicine Tags: Dtsch Arztebl Int Source Type: research
Abstract Non-vitamin K antagonist oral anticoagulants (NOACs) include dabigatran, which inhibits thrombin, and apixaban, betrixaban, edoxaban and rivaroxaban, which inhibit factor Xa. In large clinical trials comparing the NOACs with the vitamin K antagonist (VKA) warfarin, dabigatran, apixaban, rivaroxaban and edoxaban were at least as effective for stroke prevention in atrial fibrillation and for treatment of venous thromboembolism, but were associated with less intracranial bleeding. In addition, the NOACs are more convenient to administer than VKAs because they can be given in fixed doses without routine coagu...
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Tags: Thromb Haemost Source Type: research
More News: Atrial Fibrillation | Cardiology | Health | Heart | Heart Disease | Learning | Universities & Medical Training